Literature DB >> 25617694

Evolution in medicinal chemistry of ursolic acid derivatives as anticancer agents.

Haijun Chen1, Yu Gao2, Ailan Wang2, Xiaobin Zhou2, Yunquan Zheng2, Jia Zhou3.   

Abstract

Currently, there is a renewed interest in common dietaries and plant-based traditional medicines for the prevention and treatment of cancer. In the search for potential anticancer agents from natural sources, ursolic acid (UA), a pentacyclic triterpenoid widely found in various medicinal herbs and fruits, exhibits powerful biological effects including its attractive anticancer activity against various types of cancer cells. However, the limited solubility, rapid metabolism and poor bioavailability of UA restricted its further clinical applications. In the past decade, with substantial progress toward the development of new chemical entities for the treatment of cancer, numerous UA derivatives have been designed and prepared to overcome its disadvantages. Despite extensive effort, discovery of effective UA derivatives has so far met with only limited success. This review summarizes the current status of the structural diversity and evolution in medicinal chemistry of UA analogues and provides a detailed discussion of future direction for further research in the chemical modifications of UA.
Copyright © 2015 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Anticancer agents; Chemical biology; Drug discovery; Natural products; Ursolic acid derivatives

Mesh:

Substances:

Year:  2015        PMID: 25617694      PMCID: PMC4336574          DOI: 10.1016/j.ejmech.2015.01.031

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  68 in total

Review 1.  Pharmacological activities of natural triterpenoids and their therapeutic implications.

Authors:  Petr Dzubak; Marian Hajduch; David Vydra; Alica Hustova; Miroslav Kvasnica; David Biedermann; Lenka Markova; Milan Urban; Jan Sarek
Journal:  Nat Prod Rep       Date:  2006-05-03       Impact factor: 13.423

2.  Synthesis and evaluation of ursolic acid derivatives as potent cytotoxic agents.

Authors:  Kai-Kai Bai; Zhou Yu; Fen-Ling Chen; Feng Li; Wei-Yun Li; Yang-Hao Guo
Journal:  Bioorg Med Chem Lett       Date:  2012-02-10       Impact factor: 2.823

3.  Tannic acid synergizes the cytotoxicity of chemotherapeutic drugs in human cholangiocarcinoma by modulating drug efflux pathways.

Authors:  Peter J Naus; Roger Henson; Grant Bleeker; Hania Wehbe; Fanyin Meng; Tushar Patel
Journal:  J Hepatol       Date:  2006-10-06       Impact factor: 25.083

4.  Discovery of potent anticancer agent HJC0416, an orally bioavailable small molecule inhibitor of signal transducer and activator of transcription 3 (STAT3).

Authors:  Haijun Chen; Zhengduo Yang; Chunyong Ding; Ailian Xiong; Christopher Wild; Lili Wang; Na Ye; Guoshuai Cai; Rudolfo M Flores; Ye Ding; Qiang Shen; Jia Zhou
Journal:  Eur J Med Chem       Date:  2014-05-22       Impact factor: 6.514

5.  Novel nitrogen-enriched oridonin analogues with thiazole-fused A-ring: protecting group-free synthesis, enhanced anticancer profile, and improved aqueous solubility.

Authors:  Chunyong Ding; Yusong Zhang; Haijun Chen; Zhengduo Yang; Christopher Wild; Lili Chu; Huiling Liu; Qiang Shen; Jia Zhou
Journal:  J Med Chem       Date:  2013-06-19       Impact factor: 7.446

6.  Ursolic acid inhibits acid sphingomyelinase in intestinal cells.

Authors:  Ping Zhang; Yajun Cheng; Rui-Dong Duan
Journal:  Phytother Res       Date:  2012-04-17       Impact factor: 5.878

7.  Isolation of immunomodulatory triterpene acids from a standardized rose hip powder (Rosa canina L.).

Authors:  Lasse Saaby; Anna Katharina Jäger; Lise Moesby; Erik Wind Hansen; Søren Brøgger Christensen
Journal:  Phytother Res       Date:  2011-02       Impact factor: 5.878

8.  Ursolic acid in cancer prevention and treatment: molecular targets, pharmacokinetics and clinical studies.

Authors:  Muthu K Shanmugam; Xiaoyun Dai; Alan Prem Kumar; Benny K H Tan; Gautam Sethi; Anupam Bishayee
Journal:  Biochem Pharmacol       Date:  2013-03-13       Impact factor: 5.858

9.  Structure-dependent inhibition of bladder and pancreatic cancer cell growth by 2-substituted glycyrrhetinic and ursolic acid derivatives.

Authors:  Gayathri Chadalapaka; Indira Jutooru; Alan McAlees; Tom Stefanac; Stephen Safe
Journal:  Bioorg Med Chem Lett       Date:  2008-03-14       Impact factor: 2.823

Review 10.  Research progress of ursolic acid's anti-tumor actions.

Authors:  Li-li Zang; Bao-ning Wu; Yuan Lin; Jun Wang; Lei Fu; Ze-yao Tang
Journal:  Chin J Integr Med       Date:  2013-12-29       Impact factor: 1.978

View more
  29 in total

1.  Ursolic Acid Loaded PLGA Nanoparticles: in vitro and in vivo Evaluation to Explore Tumor Targeting Ability on B16F10 Melanoma Cell Lines.

Authors:  Rinku Baishya; Dipak K Nayak; Deepak Kumar; Samarendu Sinha; Amit Gupta; Shantanu Ganguly; Mita Chatterjee Debnath
Journal:  Pharm Res       Date:  2016-07-18       Impact factor: 4.200

2.  Synthesis and cytotoxic activity of novel A-ring cleaved ursolic acid derivatives in human non-small cell lung cancer cells.

Authors:  Vanessa I S Mendes; Geoffrey A Bartholomeusz; Mary Ayres; Varsha Gandhi; Jorge A R Salvador
Journal:  Eur J Med Chem       Date:  2016-07-22       Impact factor: 6.514

3.  Characterization of naturally occurring pentacyclic triterpenes as novel inhibitors of deubiquitinating protease USP7 with anticancer activity in vitro.

Authors:  Bo Jing; Meng Liu; Li Yang; Hai-Yan Cai; Jie-Bo Chen; Ze-Xi Li; Xi Kou; Yun-Zhao Wu; Dong-Jun Qin; Li Zhou; Jin Jin; Hu Lei; Han-Zhang Xu; Wei-Wei Wang; Ying-Li Wu
Journal:  Acta Pharmacol Sin       Date:  2017-11-23       Impact factor: 6.150

4.  Anti-Trichomonas vaginalis activity of ursolic acid derivative: a promising alternative.

Authors:  Fernanda Gobbi Bitencourt; Patrícia de Brum Vieira; Lucia Collares Meirelles; Graziela Vargas Rigo; Elenilson Figueiredo da Silva; Simone Cristina Baggio Gnoatto; Tiana Tasca
Journal:  Parasitol Res       Date:  2018-03-23       Impact factor: 2.289

5.  Pharmacokinetics and Pharmacodynamics of the Triterpenoid Ursolic Acid in Regulating the Antioxidant, Anti-inflammatory, and Epigenetic Gene Responses in Rat Leukocytes.

Authors:  Chengyue Zhang; Chao Wang; Wenji Li; Renyi Wu; Yue Guo; David Cheng; Yuqing Yang; Ioannis P Androulakis; Ah-Ng Kong
Journal:  Mol Pharm       Date:  2017-10-25       Impact factor: 4.939

6.  Synthesis, cytotoxicity and anti-inflammatory activity of rhamnose-containing ursolic and betulinic acid saponins.

Authors:  Balla Sylla; Serge Lavoie; Jean Legault; Charles Gauthier; André Pichette
Journal:  RSC Adv       Date:  2019-12-02       Impact factor: 4.036

Review 7.  Discovery and development of natural product oridonin-inspired anticancer agents.

Authors:  Ye Ding; Chunyong Ding; Na Ye; Zhiqing Liu; Eric A Wold; Haiying Chen; Christopher Wild; Qiang Shen; Jia Zhou
Journal:  Eur J Med Chem       Date:  2016-06-13       Impact factor: 6.514

8.  Killing of Serratia marcescens biofilms with chloramphenicol.

Authors:  Christopher Ray; Anukul T Shenoy; Carlos J Orihuela; Norberto González-Juarbe
Journal:  Ann Clin Microbiol Antimicrob       Date:  2017-03-29       Impact factor: 3.944

9.  Synthesis and biological evaluation of novel ursolic acid analogues as potential α-glucosidase inhibitors.

Authors:  Pan-Pan Wu; Bing-Jie Zhang; Xi-Ping Cui; Yang Yang; Zheng-Yun Jiang; Zhi-Hong Zhou; Ying-Ying Zhong; Yu-Ying Mai; Zhong Ouyang; Hui-Sheng Chen; Jie Zheng; Su-Qing Zhao; Kun Zhang
Journal:  Sci Rep       Date:  2017-03-30       Impact factor: 4.379

Review 10.  Conjugation of Natural Triterpenic Acids with Delocalized Lipophilic Cations: Selective Targeting Cancer Cell Mitochondria.

Authors:  Anna Yu Spivak; Darya A Nedopekina; Rinat R Gubaidullin; Mikhail V Dubinin; Konstantin N Belosludtsev
Journal:  J Pers Med       Date:  2021-05-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.